Fei joined the MIG Capital investment team in April 2023 to strengthen its Life Science division. She is a healthcare expert with a deep background in medicine and biology as well as the venture capital industry.
Prior to joining MIG, Fei worked for yabeo Venture Tech, where she managed and served as board director of the health tech portfolio. Prior to that, Fei spent nine years at Vesalius Biocapital as an investment analyst and then principal. Her work included portfolio management, deal identification, due diligence, and deal structuring in the life science investment space.
Fei studied medicine at Tongji University in PRC and worked as an emergency room doctor for two years. She then completed her Ph.D. in oncology and stem cell research at Ludwig-Maximilian-University.